A quick review of COVID-19 CLINICAL MATTERS Dr. Edsel Maurice T. Salvana The COVID-19 pandemic has changed our lives in many ways. It has also expanded our vocabulary, at least COVID-19-related terms. There remain a lot of misconceptions surrounding technical terms like strain, variant, quarantine,...
(Not just the Western ones) CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Despite record numbers of cases across the world as a result of the Delta variant rampage, death rates from COVID-19 in countries with high vaccination rates have been dropping dramatically. Along with decreasing death rates...
First-generation vaccines are not the boosters you need CLINICAL MATTERS Dr. Edsel Maurice T. Salvana As Delta variant wreaks havoc around the world, many people are starting to worry about their risk for infection and severe COVID-19. Vaccination is proceeding globally at an increasing pace. More...
Each part has its own meaning CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Twenty thousand cases. 22,000 cases. Every day at 4 p.m., people get palpitations waiting for the release of the next Department of Health COVID-19 Bulletin. Most of the attention goes to the number of new cases, followed...
The clinical trial on the use of anti-parasitic drug Ivermectin for COVID-19 patients in the country has been moved again for one more month, from Sept. 15 to Oct. 15, due to ongoing revisions on its protocols. Department of Science and Technology (DOST) Sec. Fortunato Dela Peña said in a...
Our early lockdown in March saved 200,000 lives, and continued vaccination is driving down infection numbers CLINICAL MATTERS Dr. Edsel Maurice T. Salvana Last March 2020, the first community transmission of COVID-19 in the Philippines was recorded. Given the uncertainty surrounding the virus, the...
The Department of Science and Technology (DOST) on Monday, Sept. 6, said it will release this month the results of its study on virgin coconut oil (VCO) and lagundi as potential treatments for patients with coronavirus disease (COVID-19). Department of Science and Technology Dr. Jaime Montoya,...
And what to expect in the next few months CLINICAL MATTERS Dr. Edsel Maurice T. Salvana There is an internet saying that goes, “This too shall pass. It may pass like a kidney stone, but it will pass.” I’ve never had a kidney stone, but I have had many patients who passed one. They all tell me...
The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and...
The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases. Tawa-tawa (Manila...
Avoid having ‘booster’ shots of the same vaccines—wait for the ‘souped up’ versions CLINICAL MATTERS Dr. Edsel Maurice T. Salvana On Aug. 15, 2021, the Department of Health along with the Philippine Genome Center announced the latest variant detected in the Philippines. Lambda, also known...
